5) Ions and Ach Ch 3,4 Julien and Wenk Ch3 Day 2

Day 2: Overview of Agonists, Ions, and Action Potentials

Key Topics for the Session

  • Visual review of agonist types and receptors.

  • Up and down regulation of receptors.

  • Overview of enzymes involved in neurotransmitter synthesis.

  • The role of ions, gradients, and electrical signals in neural activity.

  • Next session preview: action potentials, acetylcholine functions, and effects on sympathetic and parasympathetic systems.

Understanding Agonists and Their Effects

Types of Agonists

  1. Full Agonist: Activates the receptor completely, resulting in the maximum response.

  2. Partial Agonist: Weakly activates the receptor for a moderate effect; example includes buprenorphine for opioid receptors, useful in managing withdrawal and pain.

  3. Inverse Agonist: Reduces the receptor's activity below normal levels, eliminating constitutive activity.

  4. Allosteric Modulators: Change receptor behavior without directly activating them.

    • Positive Allosteric Modulator (PAM): Enhances receptor activation likelihood (e.g., benzodiazepines for GABA receptors).

    • Negative Allosteric Modulator (NAM): Decreases the likelihood of receptor activation, leading to reduced effects.

Affinity in Receptor Interactions

  • Affinity is the degree to which a receptor prefers a ligand. Higher affinity means a ligand will activate the receptor more effectively with lower concentrations.

    • D1 receptor has low affinity for dopamine, needing higher concentrations to activate, whereas D2 receptor has high affinity and responds to lower concentrations.

Receptor Regulation: Up and Down

Up Regulation and Down Regulation

  • Up Regulation: Increased number of receptors leading to a heightened response; typically follows antagonist exposure or decreased neurotransmitter release (e.g., Parkinson's disease results in more dopamine receptors).

  • Down Regulation: Reduced effectiveness of receptors due to prolonged agonist exposure; leads to tolerance (e.g., opioid use).

Neuroplasticity Implications

  • Changes in receptor sensitivity and quantity can have long-term effects related to drug use or neurotransmitter levels, relevant in conditions such as substance abuse and depression treatments (e.g., SSRIs).

Neurotransmitter Enzyme Functionality

Key Enzymes in Neurotransmitter Synthesis

  • Dopamine: Synthesized through the enzyme tyrosine hydroxylase converting tyrosine to L-DOPA, and then to dopamine. This process is critical in addressing dopamine deficits in conditions like Parkinson's disease.

  • GABA: Formed from glutamine, utilizing enzymes glutaminase and GAD65/67. GABA serves as the primary inhibitory neurotransmitter in the brain.

The Electrical Nature of Neurons

Resting Potential

  • Neurons maintain a resting membrane potential of approximately -70 mV due to the differential permeability of the membrane to various ions, especially potassium (K+). This is essential for the neuron's ability to produce action potentials.

Mechanisms of Voltage Regulation

  • The Sodium-Potassium Pump is crucial: it pumps 3 Na+ ions out and 2 K+ ions into the neuron, crucial for maintaining the negative potential and enabling action potentials on demand.

  • When action potentials occur, voltage-gated Na+ and K+ channels rapidly open and close, facilitating the rapid transmission of electrical signals along the neuron.

Role of Acetylcholine (ACh)

Functions and Clinical Relevance

  • CNS: Involved in learning, memory, and motor function; ACh loss is linked to Alzheimer’s disease as cholinergic neurons degenerate.

  • PNS: ACh triggers muscle contraction at the neuromuscular junction; curare blocks nicotinic ACh receptors, causing paralysis.

  • Cholinesterase inhibitors (like Galantamine) temporarily improve cognition by preventing ACh breakdown in Alzheimer’s patients.

Receptor Subtypes and Effects

  • Nicotinic Receptors: Ionotropic, contribute to the neuromuscular junction activity.

  • Muscarinic Receptors: Metabotropic, with subtypes affecting various physiological functions (e.g., heart rate reduction vs. gut activity increase). Atropine blocks certain muscarinic effects, showcasing the differential effects ACh can produce in different contexts.

Agonism and Drug Interaction

Potential Drug Effects

  • Understanding agonists, antagonists, and their modulatory effects is crucial for developing drugs that can treat various neurological disorders or manage the effects of poisons.

  • Examples include how blockers of the sodium-potassium pump can lead to toxic conditions such as migraines or seizures.

Conclusion

The interaction between receptors, ions, and neurotransmitters is complex and critical for understanding both normal brain function and the impact of various drugs and disorders. Awareness of agonist types, receptor affinities, enzyme functionalities, and the role of ACh can provide valuable insights into therapeutic avenues and the underlying principles of neurobiology.